Skip to main content
logo
Summit Therapeutics logo
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
17.59
+0.42 (2.45%)
At close: Oct 9, 2026, 4:00 PM EDT
17.55
-0.04 (-0.23%)
After-hours: Oct 9, 2026, 7:58 PM EDT

Summit Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
14,06713,48713,1601,829897263
Market Cap Growth
-18.86%2.49%619.43%103.94%241.23%-32.01%
Enterprise Value
13,39713,25412,7051,737779184
Last Close Price
17.5917.4917.842.614.252.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----1272.24145.30
PB Ratio
22.1520.4733.8523.547.083.16
P/TBV Ratio
22.4020.5334.0224.137.183.71

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----1105.42101.96

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.021.374.100.03
Net Debt / Equity Ratio
-1.06-1.05-1.04-1.031.34-0.83
Net Debt / EBITDA Ratio
0.770.631.920.91-2.730.81
Net Debt / FCF Ratio
1.462.142.851.04-4.030.95
Asset Turnover
----0.000.02
Quick Ratio
6.679.789.889.179.153.47
Current Ratio
6.969.8710.159.3016.933.80
Return on Equity (ROE)
-192.50%-206.10%-94.89%-601.85%-75.05%-108.89%
Return on Assets (ROA)
-101.61%-115.28%-41.30%-12.79%-10.23%-49.91%
Return on Capital Employed (ROCE)
-134.90%-161.40%-53.60%-48.60%-10.20%-98.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.09%-8.00%-1.68%-33.62%-8.78%-33.71%
FCF Yield
-3.27%-2.40%-1.08%-4.20%-4.71%-27.73%
Buyback Yield / Dilution
-4.03%-4.06%-15.96%-220.50%-109.60%-32.67%
SEC Filings: 10-K · 10-Q